- Pfizer (Cambridge, MA)
- …trial(s) in support of the development strategy for programs within the Late -Stage Oncology portfolio. KEY RESPONSIBILITIES Clinical development expert for ... a similar role in industry/CRO Clinical Research experience in the phase 3/pivotal space in Oncology , ideally on the side of the sponsor and with a track record of… more
- Merck & Co. (North Wales, PA)
- …health.- Responsibilities: This position supports statistical programming activities for late stage drug/vaccine clinical development projects. This may include ... leadership of one or more projects. Accountability predominantly includes the development and execution of statistical analysis and reporting deliverables (eg safety and efficacy analysis datasets, tables, listings, figures), the span of which range from… more
- Bristol Myers Squibb (Cambridge, MA)
- …of disease biology, mechanism of action, and predictive biomarkers in our late -stage clinical oncology portfolio. Ideal candidates will possess a strong ... careers.bms.com/working-with-us . Bristol Myers Squibb has pioneered the development of immuno- oncology therapies and continues to diversify in drug development for… more
- Merck & Co. (Rahway, NJ)
- …position supports statistical programming activities for multiple and/or late stage drug/vaccine clinical development projects. -Accountability predominantly ... Planning, Maintenance Strategy, Marketing, Microsoft Project, New Program Development, Oncology {+ 21 more}Current Employees apply HERE Current Contingent Workers… more
- Sumitomo Pharma (Oklahoma City, OK)
- …the US (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene therapies and CNS. With ... several marketed products and a diverse pipeline of early- to late -stage investigational assets, we aim to accelerate discovery, research, and development to bring… more
- Sumitomo Pharma (Oklahoma City, OK)
- …the US (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene therapies and CNS. With ... several marketed products and a diverse pipeline of early- to late -stage investigational assets, we aim to accelerate discovery, research, and development to bring… more
- Sumitomo Pharma (St. Paul, MN)
- …the US (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene therapies and CNS. With ... several marketed products and a diverse pipeline of early- to late -stage investigational assets, we aim to accelerate discovery, research, and development to bring… more
- Merck & Co. (CT)
- …Medical Needs Execute - Prioritize Resources Behind Our Key Growth Drivers ( Oncology , Vaccines, Select Specialty Areas, Animal Health) While Optimizing Our Base ... in the relevant therapeutic area space is highly desirable (ie, experience in late stage clinical research as an investigator or key study personnel conducting… more
- Merck & Co. (North Wales, PA)
- …Statistics and global PK/PD modeling and simulation stakeholders spanning both early and late in all our Company therapeutic areas except early oncology . -The ... senior statistical programmer will gather and interpret user requirements for analysis and programming requests in close collaboration with stakeholders (statisticians/modelers) and clinical colleagues, retrieve the required data, transform the data into… more
- Sumitomo Pharma (St. Paul, MN)
- …the US (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene therapies and CNS. With ... several marketed products and a diverse pipeline of early- to late -stage investigational assets, we aim to accelerate discovery, research, and development to bring… more
